Home Cart 0 Sign in  

[ CAS No. 1374640-70-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1374640-70-6
Chemical Structure| 1374640-70-6
Structure of 1374640-70-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1374640-70-6 ]

Related Doc. of [ 1374640-70-6 ]

Alternatived Products of [ 1374640-70-6 ]

Product Details of [ 1374640-70-6 ]

CAS No. :1374640-70-6 MDL No. :MFCD26793864
Formula : C27H28F3N7O3 Boiling Point : -
Linear Structure Formula :- InChI Key :HUFOZJXAKZVRNJ-UHFFFAOYSA-N
M.W : 555.55 Pubchem ID :57335384
Synonyms :

Calculated chemistry of [ 1374640-70-6 ]

Physicochemical Properties

Num. heavy atoms : 40
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.26
Num. rotatable bonds : 11
Num. H-bond acceptors : 8.0
Num. H-bond donors : 3.0
Molar Refractivity : 152.53
TPSA : 111.72 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.87 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.89
Log Po/w (XLOGP3) : 3.97
Log Po/w (WLOGP) : 4.98
Log Po/w (MLOGP) : 2.19
Log Po/w (SILICOS-IT) : 3.05
Consensus Log Po/w : 3.62

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.39
Solubility : 0.00225 mg/ml ; 0.00000405 mol/l
Class : Moderately soluble
Log S (Ali) : -6.02
Solubility : 0.000534 mg/ml ; 0.000000962 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -8.12
Solubility : 0.00000418 mg/ml ; 0.0000000075 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 4.12

Safety of [ 1374640-70-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1374640-70-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1374640-70-6 ]
  • Downstream synthetic route of [ 1374640-70-6 ]

[ 1374640-70-6 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 814-68-6 ]
  • [ 1374640-70-6 ]
YieldReaction ConditionsOperation in experiment
92% With triethylamine In dichloromethane at 20℃; Cooling with ice Compound (X) 40.12g (0.08mol) dissolved in 280 ml methylene chloride, then adding 16.2g (0.16mol) triethylamine, acryloyl chloride dropwise under ice bath 9.05g (0.10mol), and then room temperature reaction 4-5h. Remove the solvent under reduced pressure, to residue 200 ml water, stirring after-filtration, to obtain a kind of white solid, dichloromethane/methanol is recrystallized to get kind of white powder 41.0g, purity 99.6percent, yield 92percent.
Reference: [1] Patent: CN105461640, 2016, A, . Location in patent: Paragraph 0006; 0028; 0029
  • 2
  • [ 625-36-5 ]
  • [ 1374640-70-6 ]
YieldReaction ConditionsOperation in experiment
4.7 g With sodium hydrogencarbonate In tetrahydrofuran; water at 0℃; 5g of intermediate V with 150mlTHF dissolved, then 75ml of water was dissolved 2.3g of sodium bicarbonate and water was added to the reaction mixture a solvent, 0 placed in the reaction, the reaction liquid at this time as a red supernatant, the chloropropionyl chloride with 1.3g 75mlTHF dilution, was slowly added dropwise to the reaction mixture.TLC analysis after the addition was complete the reaction was complete feed.The reaction solution was spin to most of the tetrahydrofuran, was added 100ml of saturated aqueous sodium bicarbonate, 3 × 100ml extracted three times with ethyl acetate, the organic phases combined, dried over anhydrous sodium sulfate, filtered, and ethyl acetate was removed by rotary evaporation 2/3.Was added to the rotovap 7gDBU, 60 stirred for 12h, TLC detection starting material the reaction was complete, the aqueous solution was washed with 100ml × 3 was added, the organic phase is retained, dried over anhydrous sodium sulfate, filtered, spin-dries off-white solid, ethyl acetate was added heavy crystallized 4.7g, HPLC purity 99.6percent detection products
Reference: [1] Patent: CN105481779, 2016, A, . Location in patent: Paragraph 0013; 0047; 0048; 0049; 0050
  • 3
  • [ 7530-31-6 ]
  • [ 1374640-70-6 ]
YieldReaction ConditionsOperation in experiment
2.15 g With caesium carbonate In N,N-dimethyl-formamide at 90 - 100℃; for 12 h; Adding 2-[[4-(4-acetyl-1 -piperazinyl)-2-methoxy- phenyl]amino]-5-(trifluoromethyl)-pyrimidin-4-one (IV) (2.06 g, 5 mmol) and phosphorus oxychloride (7.5 mL) into a reaction flask, starting stirring, cooling to 0° C. or below, and dropwisely adding 3.5 mL of 2,6-dimethylpyridine. Slowly heating to 50-70° C., and stirring to react for 9 hours while maintaining the temperature. Reducing the pressure to recover the phosphorus oxychloride, cooling the residue to room temperature, and quenching the reaction with ice watet Extracting with dichloromethane for 3 times, combining organic phases, washing with water, drying with anhydrous sodium sulfate, reducing the pressure to recover the solvent, dissolving an obtained oily matter 2-[[4-(4- acetyl- 1 -piperazinyl)-2-methoxyphenyl]amino] -5-(trifluo- romethyl)-4-chloro-pyrimidine (V) with 25 mL of N,Ndimethylformamide, transferring into the reaction flask, and adding N-(3-aminophenyl)-2-acrylamide (1.0 g, 6 mmol) and a catalyst cesium carbonate (0.3 g). Stirring to react for 12 hours while maintaining the temperature at 90-110° C., and performing TLC detection until the reaction is finished. Filtering, concentrating under reduced pressure, adding ethyl acetate and water into the residue, and regulating pH to 5-6 with dilute acid. Separating out the organic phases, and extracting a water phase with ethyl acetate for 3 times. Combining the organic phases, washing the organic phases sequentially with pure water and brine, drying, performing reduced pressure distillation to recover the solvent, and washing with ethanol to obtain 2.15 g of an off-white solid rociletinib, wherein the yield is 77.5percent. Mass spec (El):El-MS mlz: 556 [M+H], ‘H NMR (DMSO-d5): ö 2.05 (s, 3H), 3.01 (m, 4H), 3.55 (m, 4H), 3.77 (m, 3H), 5.78 (d, 1H),6.25 (d, 2H), 6.44 (m, 1H), 6.61 (s, 1H), 7.17 (s, 1H), 7.28 (m, 1H), 7.52 (m, 2H), 7.76 (s, 1H), 8.08 (s, 1H), 8.28 (s, 1H), 8.63 (s, 1H), 10.21 (s, 1H).
Reference: [1] Patent: US2018/230133, 2018, A1, . Location in patent: Paragraph 0031
  • 4
  • [ 7530-31-6 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: US2018/230133, 2018, A1, . Location in patent: Paragraph 0032
  • 5
  • [ 1374507-23-9 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: WO2013/138495, 2013, A1,
[2] Patent: WO2013/138502, 2013, A1,
[3] Patent: WO2014/182593, 2014, A1,
[4] Patent: CN105481779, 2016, A,
  • 6
  • [ 1021426-42-5 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: CN105461640, 2016, A,
[2] Patent: CN105461640, 2016, A,
[3] Patent: CN105481779, 2016, A,
[4] Patent: US2018/230133, 2018, A1,
[5] Patent: US2018/230133, 2018, A1,
  • 7
  • [ 68621-88-5 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: WO2013/138495, 2013, A1,
[2] Patent: WO2013/138502, 2013, A1,
[3] Patent: WO2014/182593, 2014, A1,
  • 8
  • [ 3932-97-6 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: WO2013/138495, 2013, A1,
[2] Patent: WO2013/138502, 2013, A1,
[3] Patent: WO2014/182593, 2014, A1,
  • 9
  • [ 1374507-24-0 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: WO2013/138495, 2013, A1,
[2] Patent: WO2013/138502, 2013, A1,
[3] Patent: WO2014/182593, 2014, A1,
  • 10
  • [ 1374507-25-1 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: WO2013/138502, 2013, A1,
[2] Patent: WO2014/182593, 2014, A1,
  • 11
  • [ 1116229-11-8 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: CN105461640, 2016, A,
[2] Patent: CN105461640, 2016, A,
  • 12
  • [ 448-19-1 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: CN105461640, 2016, A,
[2] Patent: CN105461640, 2016, A,
  • 13
  • [ 13889-98-0 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: CN105461640, 2016, A,
[2] Patent: CN105461640, 2016, A,
  • 14
  • [ 54-20-6 ]
  • [ 1374640-70-6 ]
Reference: [1] Patent: US2018/230133, 2018, A1,
[2] Patent: US2018/230133, 2018, A1,
Same Skeleton Products
Historical Records